Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 30 Jun 2026 for Monte Rosa Therapeutics, Inc., €113k.
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Filip Janku: trading record in brief
Filip Janku appears in our data through filings on Monte Rosa Therapeutics, Inc. shares, published by SEC (Form 4). The record holds 4 filings, for trades running from 23 June 2026 to 30 June 2026.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
On 30 June 2026 came the latest disclosure, a transaction for €113k in Monte Rosa Therapeutics, Inc. Publication is fast: at least half of the trades appear on SEC (Form 4) on the same day. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Filip Janku
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
5,407 shares@ US$23.900.0063% mcap100.0% of flowCommonSEC144:0001950047-26-006665
6,000 shares@ US$22.29100.0% of flowCommonSEC144:0001950047-26-006612
30,000 shares@ US$20.71CommonSEC144:0001950047-26-006456
11,845 shares@ US$18.67CommonSEC144:0001950047-26-006428
4 of 4 declarations
